Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Dihydropteridine reductase | Starlite/ChEMBL | References |
Homo sapiens | quinoid dihydropteridine reductase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Probable short-chain type oxidoreductase | quinoid dihydropteridine reductase | 244 aa | 248 aa | 25.4 % |
Drosophila melanogaster | CG4842 gene product from transcript CG4842-RA | Dihydropteridine reductase | 241 aa | 203 aa | 22.7 % |
Loa Loa (eye worm) | hypothetical protein | Dihydropteridine reductase | 241 aa | 216 aa | 25.0 % |
Onchocerca volvulus | Dihydropteridine reductase | 241 aa | 229 aa | 24.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0052 | 0.0657 | 0.1434 |
Echinococcus granulosus | NADP binding domain | 0.0192 | 0.458 | 0.4199 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0029 | 0 | 0.5 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0056 | 0.0776 | 0.0303 |
Leishmania major | quinonoid dihydropteridine reductase | 0.0202 | 0.4841 | 1 |
Schistosoma mansoni | dihydropteridine reductase | 0.0192 | 0.458 | 1 |
Leishmania major | quinonoid dihydropteridine reductase | 0.0202 | 0.4841 | 1 |
Leishmania major | quinonoid dihydropteridine reductase | 0.0202 | 0.4841 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0056 | 0.0776 | 0.1693 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0029 | 0 | 0.5 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0052 | 0.0657 | 0.1434 |
Leishmania major | quinonoid dihydropteridine reductase | 0.0202 | 0.4841 | 1 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0029 | 0 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0029 | 0 | 0.5 |
Loa Loa (eye worm) | dihydropteridine reductase-PC | 0.0192 | 0.458 | 1 |
Echinococcus multilocularis | NAD(P) binding domain | 0.0192 | 0.458 | 0.4199 |
Trypanosoma cruzi | quinonoid dihydropteridine reductase, putative | 0.0202 | 0.4841 | 1 |
Echinococcus multilocularis | tumor protein p63 | 0.0386 | 1 | 1 |
Brugia malayi | dihydropteridine reductase-like | 0.0192 | 0.458 | 1 |
Leishmania major | quinonoid dihydropteridine reductase | 0.0202 | 0.4841 | 1 |
Toxoplasma gondii | 6,7-dihydropteridine reductase | 0.0192 | 0.458 | 1 |
Leishmania major | quinonoid dihydropteridine reductase | 0.0202 | 0.4841 | 1 |
Onchocerca volvulus | 0.0056 | 0.0776 | 0.5 | |
Leishmania major | quinonoid dihydropteridine reductase | 0.0202 | 0.4841 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
I50 (binding) | = 0.00000025 M | Inhibitory activity against rat striatal synaptosomes Dihydrodipicolinate reductase | ChEMBL. | 3871859 |
I50 (binding) | = 0.00000028 M | Inhibitory activity against human liver Dihydrodipicolinate reductase | ChEMBL. | 3871859 |
IC50 (binding) | = 0.00000025 M | Inhibitory activity against rat striatal synaptosomes Dihydrodipicolinate reductase | ChEMBL. | 3871859 |
IC50 (binding) | = 0.00000028 M | Inhibitory activity against human liver Dihydrodipicolinate reductase | ChEMBL. | 3871859 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.